| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |